Business ServicesCompany
Royalty Pharma M&A Summary
Royalty Pharma has acquired 3 companies, including 2 in the last 5 years.
Royalty Pharma’s largest acquisition to date was in 2017, when it acquired TYSABRI for $2.9B. Royalty Pharma has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Royalty Pharma Business Overview
Where is Royalty Pharma headquartered?
Royalty Pharma is headquartered in New York, New York.
What is Royalty Pharma’s revenue?
Royalty Pharma disclosed revenue of 2,354M USD for 2023 and 2,237M USD for 2022.
What sector is Royalty Pharma in?
Royalty Pharma is a business services company.
When was Royalty Pharma founded?
Royalty Pharma was founded in 1996.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
- M&A Advisors 3